Sylvestre Quevedo, MD
President and Director of research
Sylvestre Quevedo is currently Associate Professor of Medicine at UCSF, a Principal Investigator in an FDA trial of MDMA-assisted therapy for PTSD with the Multidisciplinary Association for Psychedelic Studies and UCSF.
He earned his medical degree at the Harvard Medical School and a Master of Public Health degree at Harvard School of Public Health. After postdoctoral training in family and community medicine at the University of Arizona, he spent four years developing community health center programs in underserved communities in Colorado, Washington and California.
He returned to postdoctoral education with studies in law and public policy at the Stanford Law School, followed by internal medicine at Stanford and a fellowship in nephrology and medicine at Stanford University Medical Center, where he was a Robert Wood Johnson Foundation Clinical Scholar. As Assistant Professor of Medicine at the Stanford Medical School he taught in the core nephrology rotation for Stanford medical students, residents, and fellows.
He also served as Associate Chief of Nephrology and Medical Director of the Artificial Kidney Center at the Santa Clara Valley Medical Center, a Stanford teaching hospital where he directed the hemodialysis and peritoneal dialysis programs. He went on to become the founding director of the Center for Integrative Medicine at the O’Connor Hospital in San Jose.
He was then named the Osher Foundation Associate Professor of Medicine at the University of California, San Francisco (UCSF) where he was Director of Clinical Programs at the Osher Center for Integrative Medicine. He spent a sabbatical year at Duke University School of Medicine as Associate Professor of Medicine and Consulting Medical Director for Duke Integrative Medicine where he worked at the senior executive level with the Duke University Health System.
He returned to UCSF in the Global Health Sciences group and Department of Medicine and was involved in medical education reform, ambulatory care redesign, international health efforts (East Africa) and public-private partnerships in healthcare. He has advised several health IT start-ups, most recently on bundled care initiatives and value-based purchasing.
He was founding Chief Medical Officer of Health Qx of Philadelphia, an advanced healthcare analytics startup that was acquired by McKesson in 2016. He is currently Associate Professor of Medicine at UCSF, a Principal Investigator in an FDA trial of MDMA-assisted therapy for PTSD with the Multidisciplinary Association for Psychedelic Studies and UCSF and a partner at Mside Solutions of Philadelphia, an advanced healthcare analytics consultancy.
Dr. Quevedo has served on national boards and committees of the American Kidney Fund, the Institute of Medicine of the National Academy of Sciences, and the American College of Physicians. He is Chairman of the Board of the Trust for Indigenous Culture and Health of Nairobi, Kenya and New York, NY and has been a Visiting Professor with the Aga Khan University in Nairobi, Kenya and the University of Central Asia in Bishkek, Kyrgyzstan.